insights

Premenstrual Dysphoric Disorder (PMDD)

Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS). Approximately 5% of women meet the diagnostic criteria for PMDD, which is comprised of psychological and somatic symptoms as well as functional impairment.1 In the following video, IFM educator Monique Class, MS, APRN, BC, IFMCP, discusses strategies for assessing patients with PMDD and shows how a practitioner-patient collaboration during this assessment may better inform treatment considerations.

Transcript

PMDD is a version of PMS, but there’s more depression with it, and sometimes anxiety. It happens right before the menstrual period, and it typically ends two to three days after the menses stops.

What I am looking for is:

  • What are the triggers?
  • What are the cues?
  • What goes on around them that makes this happen?

Then I look at a month-long salivary test, or check out a urine test so that I can really understand what is going on with the hormones during that time.

But it’s not just about the hormones; it’s what’s going on in their life.

Because there is a tipping point during that phase of—that luteal phase where, as the hormones shift, their ability to handle the allostatic load of their life changes.

You have to look at it from all dimensions—what’s going on in their life that they need to take a time out from, and what’s going on with the distribution of the hormones that I can go in and rebalance in various ways.

Learn more about Functional Medicine

Learn More About Functional Medicine

References

  1. Lanza di Scalea T, Pearlstein T. Premenstrual dysphoric disorder. Psychiatr Clin North Am. 2017;40(2):201-216. doi:10.1016/j.psc.2017.01.002

Related Insights

Insights
Group 2

Menarche, Menopause, and Endocrine-Disrupting Chemicals

An increasing amount of research published over the past few years suggests that female reproductive health may be affected by a wide range of chemicals present both in the environment and within consumer products. Educating people about endocrine-disrupting chemicals (EDCs), including guidance about potentially problematic ingredients in personal care products, may help reduce exposure.

Read More
Insights
Group 2

Reducing Chronic Disease Risk at Menopause Using Nutrition

The hormone fluctuations of perimenopause and menopause come with increased health risks for many patients. What is the role of nutrition in health promotion for these patients?

Read More
Insights
Group 2

Women's Health: Supporting Ovary Function and Longevity

IFM staff member Kalea Wattles, ND, shares how empowering it can be for patients to understand how they can improve ovarian function. True preventative medicine starts with education at an early age. Listen to the full video here.

Read More